Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1995
11/09/1995WO1995029929A1 Novel erythromycin derivatives, method for their preparation and their use as drugs
11/09/1995WO1995029923A1 Process for the preparation of mono- and bis(phosphocholine) derivatives which have antifungal activity
11/09/1995WO1995029922A1 Methanol derivatives for treatment of retroviral infections especially hiv infections
11/09/1995WO1995029919A1 Preparation of a camptothecin derivative by intramolecular cyclisation
11/09/1995WO1995029917A2 Intermediates in pharmaceutical camptothecin preparation
11/09/1995WO1995029916A1 Electron-deficient porphyrins and processes and intermediates for preparing same
11/09/1995WO1995029915A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds
11/09/1995WO1995029911A1 Benzofuran derivatives as d4 receptor antagonists
11/09/1995WO1995029909A1 Novel acyclic and cyclic amides as neurotransmitter release enhancers
11/09/1995WO1995029907A1 Benzofuran derivatives useful as inhibitors of bone resorption
11/09/1995WO1995029900A1 CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS GnRH ANTAGONISTS
11/09/1995WO1995029897A1 METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS
11/09/1995WO1995029895A1 Dihydrodibenzo(de,h)isoquinolines derivatives and their use as anti-cancer agents
11/09/1995WO1995029894A1 Novel quinolone 5-(n-heterosubstituted amino) antimicrobials
11/09/1995WO1995029706A1 TIN-117m-CONTAINING RADIOTHERAPEUTIC AGENTS
11/09/1995WO1995029702A1 Texaphyrin solid-supports and devices
11/09/1995WO1995029692A1 An advanced glycosylation endproduct-receptor, and diagnostic and therapeutic methods based thereon
11/09/1995WO1995029683A1 Pharmaceutical composition comprising hyaluronic acid for the clearing of arteriosclerosis
11/09/1995WO1995029682A1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWIS?a¿
11/09/1995WO1995029680A1 New method of treatment
11/09/1995WO1995029679A1 Wet granulation formulation for bisphosphonic acids
11/09/1995WO1995029678A1 Pharmaceutical composition for transdermal delivery
11/09/1995WO1995029677A1 Lactone stable formulation of camptothecin or 7-ethyl camptothecin
11/09/1995WO1995029676A1 Human body weight management
11/09/1995WO1995029675A1 Method and composition for treating renal disease and failure
11/09/1995WO1995029674A1 A method of modifying angiotensin receptor activity for treatment of premenstrual syndrome and mediation of pain
11/09/1995WO1995029673A1 Methods for modulating t cell responses by manipulating intracellular signal transduction
11/09/1995WO1995029672A1 HALOMETHYL AMIDES AS IL-1β PROTEASE INHIBITORS
11/09/1995WO1995029671A1 Benzoquinon alkanoic acids for treating preeclampsia
11/09/1995WO1995029670A1 Pharmaceutical composition and methods of treatment
11/09/1995WO1995029669A2 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
11/09/1995WO1995029668A1 Nutritional supplement for optimizing cellular health
11/09/1995WO1995029666A1 Sustained-release pharmaceutical system for the delivery of antioxidants
11/09/1995WO1995029665A1 Effective dosage form for antiepileptic drugs
11/09/1995WO1995025548A3 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives
11/09/1995WO1995024896A3 Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne
11/09/1995WO1995024190A3 Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
11/09/1995DE4415553A1 Use of deoxyspergualin to prepare medicament
11/09/1995DE19515650A1 New 8-O-Methyl purpuro-galline carboxylic acid
11/09/1995CA2575042A1 Effective dosage form for antiepileptic drugs
11/09/1995CA2189435A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds
11/09/1995CA2189070A1 Method and composition for treating renal disease and failure
11/09/1995CA2189053A1 Condensed heterocyclic compounds, their production and use as gnrh antagonists
11/09/1995CA2189036A1 Halomethyl amides as il-1.beta. protease inhibitors
11/09/1995CA2189013A1 Binding of e-selectin, p-selectin or l-selectin to sialyl-lewisx or sialyl-lewisa
11/09/1995CA2188949A1 Benzofuran derivatives as d4 receptor antagonists
11/09/1995CA2188918A1 Novel quinolone 5-(n-heterosubstituted amino) antimicrobials
11/09/1995CA2188833A1 Dihydrodibenzo(de,h)isoquinolines derivatives and their use as anti-cancer agents
11/09/1995CA2188760A1 Process for the preparation of 4-amino-3-ketosteroids via 4-nitro-4-3-ketosteroids
11/09/1995CA2188569A1 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
11/09/1995CA2187949A1 Electron-deficient porphyrins and processes and intermediates for preparing same
11/09/1995CA2168441A1 Nutritional supplement for optimizing cellular health
11/08/1995EP0680969A2 Modified oligonucleotides, their preparation and their use
11/08/1995EP0680967A1 Erythromycin derivatives, their process of preparation and their use as medicaments
11/08/1995EP0680964A1 NEW PIRROLO 3,2-e]INDOL DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS
11/08/1995EP0680963A1 (Hydroxyphenylamino)carbonyl pyrroles
11/08/1995EP0680962A2 Heterocyclic compounds
11/08/1995EP0680953A1 1-[Styryl]- and 1-[2'-(heteroaryl)-ethenyl]-isoquinoline derivatives, a process for preparing them as well as medicaments containing them and the use of them
11/08/1995EP0680945A2 Amino acid, carnitine and magnesium supplementation
11/08/1995EP0680761A1 Topical medicament having cicatrizing activity
11/08/1995EP0680760A1 Topical antipruritic composition containing a phosphonic acid diester compound
11/08/1995EP0680759A1 Transdermal delivery of calcium channel blockers, such as nifedipine
11/08/1995EP0680758A1 Pharmaceutical compositions containing tamoxifen or analogs and raloxifene or analogs
11/08/1995EP0680757A2 Use of active substances protected against degradation in the rumen of ruminants as hepatoprotector
11/08/1995EP0680756A1 Use of a combination of antineoplastons for the manufacture of a medicament for the treatment of neurofibromatosis
11/08/1995EP0680755A1 Method for treating inflammation, ischemia-induced cell damage and muscular dystrophy
11/08/1995EP0680754A2 Percutaneous absorption preparation containing Buprenorphine
11/08/1995EP0680752A2 Conditioned water soluble substances
11/08/1995EP0680750A1 Topical cosmetic or pharmaceutic composition
11/08/1995EP0680749A2 Cosmetic composition comprising an antagonist of substance P
11/08/1995EP0680748A1 Cosmetic and/or dermatological composition containing a cationic polymeric gelling agent and its uses especially for skin depigmentation
11/08/1995EP0680747A1 Cosmetic and/or dermatologic composition containing a glycerol tri(alpha-hydroxyacylate) as sole precursor of glycerol
11/08/1995EP0680745A2 Use of antifungals and or halogenated antibacterial agents for diminishing hair loss
11/08/1995EP0680489A1 Foldback triplex-forming oligonucleotides
11/08/1995EP0680488A1 2,6-diaminopurine derivatives
11/08/1995EP0680478A1 N,N'-CYCLOALKYL/ALKYL CARBOXAMIDE 4H-IMIDAZO 4,5-b]PYRIDINE COMPOUNDS AS PAF ANTAGONISTS
11/08/1995EP0680475A1 Novel substituted thiosemicarbazonic acid esters
11/08/1995EP0680474A1 Novel substitued thiosemicarbazonethiones
11/08/1995EP0680473A1 Novel substituted thiosemicarbazone derivatives
11/08/1995EP0680472A1 4,5-diphenylimidazole derivatives, their preparation and their use as acyl coenzyme a: cholesterol-0-acyl-transferase (acat) inhibitor
11/08/1995EP0680470A1 Diarylalkyl piperidines useful as multi-drug resistant tumor agents.
11/08/1995EP0680469A1 Aminoacid derivates, medicaments containing these compounds and process for preparing the same
11/08/1995EP0680468A1 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte aggregation
11/08/1995EP0680338A1 Ganglioside-klh conjugate vaccines with qs-21
11/08/1995EP0680336A1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants
11/08/1995EP0680333A1 Prevention and treatment of cytomegalovirus using aminopeptidase
11/08/1995EP0680332A1 Combination of a soluble complement receptor -1(scr1) and an amidinophenyl or amidino naphthyl-ester for treating inflammation
11/08/1995EP0680330A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1
11/08/1995EP0680329A1 Prevention and treatment of myocardial failure
11/08/1995EP0680327A1 Therapeutic uses and delivery systems of dehydroepiandrosterone
11/08/1995EP0680326A1 Pharmaceutical composition for treating nicotine dependence.
11/08/1995EP0680325A1 Transdermal therapeutic system with galanthamine as active ingredient
11/08/1995EP0680324A1 Method and composition employing (2r,4s) itraconazole
11/08/1995EP0680323A1 Synergising association having an antagonist effect on nk1 and nk2 receptors.
11/08/1995EP0680322A1 Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
11/08/1995EP0680321A1 Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide
11/08/1995EP0680320A1 Stable oral ci-981 formulation and process of preparing same
11/08/1995EP0680319A1 Nitroglycerine-containing plaster, process for producing the same and its use.
11/08/1995EP0680318A1 Method for increasing the efficiency of feed conversion in animals
11/08/1995EP0680317A1 Method for treating a medical patient for cardiac trauma
1 ... 6969 6970 6971 6972 6973 6974 6975 6976 6977 6978 6979 6980 6981 6982 6983 6984 6985 6986 6987 6988 6989 ... 7860